USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Innovation Culture in the Life Sciences Sector Enables Growth Despite the Short-term Impact of COVID-19 and Brexit
30-Nov-2020
Europe
Market Research
MF68-01-00-00-00
HC03360-EU-MT_24993
The United Kingdom (UK) medical technology (MedTech) market is experiencing a transformational phase. Although it achieved steady growth up to 2019 and was infused with investments as part of the UK Life Sciences Sector Deal, market and regulatory challenges persist. In this research study, Frost & Sullivan analyzes the UK MedTech market landscape including discussion of trends, drivers, and restraints; and a forecast assessment. The study examines historical data on revenue turnover from the Office of Life Sciences and offers a forecast in consideration of several factors including Brexit; COVID-19; and the milestones earmarked in the UK Life Sciences Sector Deal, Life Sciences Recovery Roadmap, and other relevant strategic initiatives.
The study also identifies growth opportunities in light of recent market developments and presents an evaluation of the investments outlined by the Life Sciences Sector Deal. It covers the growth environment with specific focus on clusters within the UK MedTech sector.
Market segmentation is broken down into two main parts, MedTech core and services and supply, with MedTech core sub-segmented into medical devices, in-vitro diagnostics (IVD), and digital health. Revenue forecasts are provided for each segment. The study period is from 2015 to 2023.
Author: Shruthi Parakkal
Purpose of this Experiential Study
Growth Opportunities Fuel the Growth Pipeline Engine™
Strategic Imperatives for Companies in the Market
UK MedTech Market—Segmentation and Definitions
UK MedTech Market—Market Segmentation Categories
UK MedTech Market—Market Segmentation Categories (continued)
UK MedTech Market—Competitive Landscape
UK MedTech Market—Key Performance Indicators
Drivers and Restraints
Market Forecast Methodology
UK MedTech Market Forecast
UK MedTech Market Forecast (continued)
UK MedTech Market Forecast (continued)
UK MedTech Market Forecast (continued)
UK MedTech Market Forecast (continued)
UK MedTech Market Forecast (continued)
UK MedTech Market Forecast (continued)
UK MedTech Market Forecast (continued)
UK MedTech Market Forecast (continued)
UK MedTech Market
UK MedTech Market Numbers
UK MedTech Market Numbers
COVID-19 Impact and Response
Macro to Micro Visioning
Trends and Factors Impacting the UK MedTech Market
Trends and Factors Impacting the UK MedTech Market (continued)
Trends and Factors Impacting the UK MedTech Market (continued)
Trends and Factors Impacting the UK MedTech Market (continued)
Trends and Factors Impacting the UK MedTech Market (continued)
Trends and Factors Impacting the UK MedTech Market (continued)
Top Predictions for the UK MedTech Market
Top Predictions for the UK MedTech Market (continued)
Opportunities across the UK Life Sciences Clusters
Identifying Clusters
Golden Triangle (Cambridge, Oxford, and London)
Identifying Clusters
North-West Cluster (Liverpool, Manchester, Leeds, and Sheffield)
Midlands Cluster (Birmingham, Nottingham, Leicester, Coventry, and Derby)
Northern Cluster (Edinburgh, Glasgow, Newcastle, and Durham)
South-West Cluster (Cardiff, Bristol, and Exeter)
Sutton (London and Surrey)
TEES Valley Cluster (Middlesbrough, Stockton-on-tees, and Darlington)
Levers for Growth
Introduction to Growth Opportunities
Assessing Short-term and Long-term Impacts on Growth Opportunities
Assessing Short-term and Long-term Impacts on Growth Opportunities (continued)
Growth Opportunity 1—Near Shoring of Product Development
Growth Opportunity 1—Near Shoring of Product Development (continued)
Growth Opportunity 2—Geographic Hotspots of Collaboration
Growth Opportunity 2—Geographic Hotspots of Collaboration (continued)
Growth Opportunity 2—Geographic Hotspots of Collaboration (continued)
Growth Opportunity 2—Geographic Hotspots of Collaboration (continued)
Growth Opportunity 3—Enhancing R&D Efficiency
Growth Opportunity 3—Enhancing R&D Efficiency (continued)
Growth Opportunity 3—Enhancing R&D Efficiency (continued)
Growth Opportunity 4—Manufacturing 4.0
Growth Opportunity 4—Manufacturing 4.0 (continued)
Growth Opportunity 4—Manufacturing 4.0 (continued)
Growth Opportunity 5—Digitalization
Growth Opportunity 5—Digitalization (continued)
Growth Opportunity 5—Digitalization (continued)
Legal Disclaimer
Research Methodology for Cluster Identification
Research Methodology for Cluster Identification (continued)
Data Sources
List of Exhibits
Speak directly with our analytics experts for tailored recommendations.
Recent related Advanced Medical Technologies research
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
25 Aug 2026 | Global | Technology Research
Breakthrough Innovations in Point-of-Care Diagnostics
This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.The study assesses key technology shifts, including rapid molecular testing, ...
25 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Digital Biomarkers
A digital biomarker refers to measurable data about physiological functions or behaviors collected through digital devices and technologies, such as wearables, implants, ingestible sensors, smartphones, and mobile applications. These biomarkers provide continuous, real-time insights into an individu...
21 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease...
04 Aug 2026 | Global | Market Research
Global Capnography Devices Market, Forecast to 2031
The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring ...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Shruthi Parakkal |
| Industries | Healthcare |
| WIP Number | MF68-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9575-B1,9600-B1,9612-B1,9570-B1,9573-B1,9A48-B1,9A4B-B1,9614-B1,9627-B1 |
Investment in Genomics, Advanced Therapies, and Precision Health Offers New Opportunities for the UK MedTech Market
$4,950.00
Special Price $3,712.50 save 25 %